2024 Q2 Form 10-Q Financial Statement
#000143774924015111 Filed on May 07, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $7.042M | $4.957M |
YoY Change | 28.95% | -31.97% |
Cost Of Revenue | $4.090M | $2.928M |
YoY Change | 18.04% | -34.67% |
Gross Profit | $2.952M | $2.029M |
YoY Change | 47.9% | -27.66% |
Gross Profit Margin | 41.92% | 40.93% |
Selling, General & Admin | $3.245M | $3.345M |
YoY Change | 11.32% | 3.08% |
% of Gross Profit | 109.93% | 164.86% |
Research & Development | $422.0K | $376.0K |
YoY Change | 2.18% | 72.48% |
% of Gross Profit | 14.3% | 18.53% |
Depreciation & Amortization | $96.00K | $80.00K |
YoY Change | 2.13% | 1.27% |
% of Gross Profit | 3.25% | 3.94% |
Operating Expenses | $3.667M | $3.721M |
YoY Change | 10.19% | 7.45% |
Operating Profit | -$715.0K | -$1.692M |
YoY Change | -46.32% | 157.14% |
Interest Expense | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
% of Operating Profit | ||
Other Income/Expense, Net | -$34.00K | $1.673M |
YoY Change | 142.86% | -1958.89% |
Pretax Income | -$415.0K | $292.0K |
YoY Change | -60.25% | -170.53% |
Income Tax | $6.000K | $11.00K |
% Of Pretax Income | 3.77% | |
Net Earnings | -$421.0K | $281.0K |
YoY Change | -59.67% | -167.87% |
Net Earnings / Revenue | -5.98% | 5.67% |
Basic Earnings Per Share | -$0.01 | $0.01 |
Diluted Earnings Per Share | -$0.01 | $0.01 |
COMMON SHARES | ||
Basic Shares Outstanding | 30.39M | 30.39M |
Diluted Shares Outstanding | 30.48M | 30.76M |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $20.07M | $23.25M |
YoY Change | -28.28% | -13.12% |
Cash & Equivalents | $10.40M | $11.38M |
Short-Term Investments | $9.669M | $11.87M |
Other Short-Term Assets | $1.117M | $1.295M |
YoY Change | -13.21% | -4.07% |
Inventory | $462.0K | $537.0K |
Prepaid Expenses | ||
Receivables | $8.651M | $7.104M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $30.30M | $32.19M |
YoY Change | -17.17% | -9.01% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $4.571M | $4.572M |
YoY Change | 4.65% | 4.62% |
Goodwill | $2.116M | $2.116M |
YoY Change | 0.0% | 0.0% |
Intangibles | $337.0K | $343.0K |
YoY Change | -11.78% | -14.46% |
Long-Term Investments | $10.36M | $8.879M |
YoY Change | 112.56% | 25.87% |
Other Assets | $756.0K | $764.0K |
YoY Change | -4.18% | -4.02% |
Total Long-Term Assets | $18.69M | $17.26M |
YoY Change | 43.51% | 15.79% |
TOTAL ASSETS | ||
Total Short-Term Assets | $30.30M | $32.19M |
Total Long-Term Assets | $18.69M | $17.26M |
Total Assets | $48.99M | $49.45M |
YoY Change | -1.24% | -1.66% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $2.938M | $1.852M |
YoY Change | -5.13% | -49.27% |
Accrued Expenses | $1.190M | $1.817M |
YoY Change | 9.07% | 65.63% |
Deferred Revenue | $276.0K | $761.0K |
YoY Change | -70.58% | 78.22% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $4.482M | $4.530M |
YoY Change | -12.56% | -12.46% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $276.0K | $276.0K |
YoY Change | -1.43% | -0.36% |
Total Long-Term Liabilities | $276.0K | $276.0K |
YoY Change | -1.43% | -0.36% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $4.482M | $4.530M |
Total Long-Term Liabilities | $276.0K | $276.0K |
Total Liabilities | $5.425M | $5.490M |
YoY Change | -8.96% | -3.35% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$117.7M | -$117.2M |
YoY Change | 0.19% | 0.72% |
Common Stock | $165.4M | $165.3M |
YoY Change | 0.26% | 0.27% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $43.57M | $43.96M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $48.99M | $49.45M |
YoY Change | -1.24% | -1.66% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$421.0K | $281.0K |
YoY Change | -59.67% | -167.87% |
Depreciation, Depletion And Amortization | $96.00K | $80.00K |
YoY Change | 2.13% | 1.27% |
Cash From Operating Activities | -$1.589M | -$1.075M |
YoY Change | 60.02% | -206.44% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $90.00K | $114.0K |
YoY Change | 23.29% | 280.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $784.0K | -$4.891M |
YoY Change | 56.8% | -43.68% |
Cash From Investing Activities | $694.0K | -$5.005M |
YoY Change | 62.53% | -42.57% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | -95.00K | $0.00 |
YoY Change | -326.19% | |
NET CHANGE | ||
Cash From Operating Activities | -1.589M | -$1.075M |
Cash From Investing Activities | 694.0K | -$5.005M |
Cash From Financing Activities | -95.00K | $0.00 |
Net Change In Cash | -990.0K | -$6.196M |
YoY Change | 88.93% | -18.79% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.589M | -$1.075M |
Capital Expenditures | $90.00K | $114.0K |
Free Cash Flow | -$1.679M | -$1.189M |
YoY Change | 57.5% | -221.33% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2024Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
18763000 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
18703000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
483000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
468000 | usd |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
40000000 | |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31361303 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31361303 | |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30385297 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30825297 | |
CY2023Q4 | ftek |
Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
|
0 | pure |
CY2023Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
976006 | |
CY2023Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2251000 | usd |
CY2024Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
2 | pure |
CY2023Q1 | us-gaap |
Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
|
0 | usd |
CY2023Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
159000 | usd |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2023Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-03-31 | |
CY2024Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q1 | dei |
Entity File Number
EntityFileNumber
|
001-33059 | |
CY2024Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2024Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-5657551 | |
CY2024Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
27601 Bella Vista Parkway | |
CY2024Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Warrenville | |
CY2024Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
IL | |
CY2024Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
60555-1617 | |
CY2024Q1 | dei |
City Area Code
CityAreaCode
|
630 | |
CY2024Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
845-4500 | |
CY2024Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock | |
CY2024Q1 | dei |
Trading Symbol
TradingSymbol
|
FTEK | |
CY2024Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2024Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
30385297 | |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11382000 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17578000 | usd |
CY2024Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
11872000 | usd |
CY2023Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
12136000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7104000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6729000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
537000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
439000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1295000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1439000 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
32190000 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
38321000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4572000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4539000 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
2116000 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
2116000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
343000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
358000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
582000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
609000 | usd |
CY2024Q1 | us-gaap |
Long Term Investments
LongTermInvestments
|
8879000 | usd |
CY2023Q4 | us-gaap |
Long Term Investments
LongTermInvestments
|
3664000 | usd |
CY2024Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
764000 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
781000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
49446000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
50388000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1852000 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2421000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
105000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
81000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1289000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1252000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1284000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1934000 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4530000 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
5688000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
512000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
533000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
172000 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
172000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
276000 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
281000 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
5490000 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
6674000 | usd |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
313000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
313000 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
164957000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
164853000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-117248000 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-117529000 | usd |
CY2024Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1891000 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1748000 | usd |
CY2024Q1 | us-gaap |
Convertible Debt
ConvertibleDebt
|
76000 | usd |
CY2023Q4 | us-gaap |
Convertible Debt
ConvertibleDebt
|
76000 | usd |
CY2024Q1 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2251000 | usd |
CY2023Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2251000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
43956000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
43714000 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
49446000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
50388000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2928000 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
4482000 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3345000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3245000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
376000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
218000 | usd |
CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
6649000 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
7945000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1692000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-658000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
-0 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
5000 | usd |
CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
311000 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
339000 | usd |
CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
1673000 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-90000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
292000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-414000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
11000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-0 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
281000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-414000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.01 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.01 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30385000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30296000 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30756000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30296000 | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
281000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-414000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-143000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
86000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
138000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-328000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44841000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-414000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
86000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
89000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
44602000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
43714000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
281000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-143000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
104000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
43956000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
281000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-414000 | usd |
CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
80000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
79000 | usd |
CY2024Q1 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
16000 | usd |
CY2023Q1 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
11000 | usd |
CY2024Q1 | us-gaap |
Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
|
9000 | usd |
CY2023Q1 | us-gaap |
Interest And Dividend Income Securities Held To Maturity
InterestAndDividendIncomeSecuritiesHeldToMaturity
|
95000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
104000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
89000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-1250000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-990000 | usd |
CY2024Q1 | ftek |
Increase Decrease Employee Retention Credit Receivable
IncreaseDecreaseEmployeeRetentionCreditReceivable
|
1677000 | usd |
CY2023Q1 | ftek |
Increase Decrease Employee Retention Credit Receivable
IncreaseDecreaseEmployeeRetentionCreditReceivable
|
-0 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
99000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
116000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-151000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-51000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-563000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
934000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-609000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-519000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1075000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
1010000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
114000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
30000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
7641000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
9685000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
2750000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
1000000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5005000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-8715000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-116000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
75000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6196000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-7630000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
17578000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
23328000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11382000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
15698000 | usd |
CY2024Q1 | ftek |
Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
|
1677000 | usd |
CY2022Q4 | ftek |
Investment Plan Maximum Amount Approved
InvestmentPlanMaximumAmountApproved
|
20000000 | usd |
CY2024Q1 | us-gaap |
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
|
20751000 | usd |
CY2023Q4 | us-gaap |
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
|
15800000 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
6000 | usd |
CY2023Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
0 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
92000 | usd |
CY2023Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
86000 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
20665000 | usd |
CY2023Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
15714000 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
11872000 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
11824000 | usd |
CY2024Q1 | ftek |
Debt Securities Heldtomaturity Amortized Cost After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityAmortizedCostAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
|
8879000 | usd |
CY2024Q1 | ftek |
Debt Securities Heldtomaturity Fair Value Maturity Allocated And Single Maturity Date After Year One Through Two
DebtSecuritiesHeldtomaturityFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughTwo
|
8841000 | usd |
CY2024Q1 | us-gaap |
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss
|
20751000 | usd |
CY2024Q1 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
20665000 | usd |
CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
110000 | usd |
CY2023 | ftek |
Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
|
24000 | usd |
CY2023 | ftek |
Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
|
23000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2024Q1 | ftek |
Provision For Doubtful Accounts Including Foreign Impact Of Foreign Exchange
ProvisionForDoubtfulAccountsIncludingForeignImpactOfForeignExchange
|
0 | usd |
CY2024Q1 | ftek |
Allowance For Doubtful Accounts Receivable Chargeoffs Recoveries
AllowanceForDoubtfulAccountsReceivableChargeoffsRecoveries
|
-0 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
761000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1279000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
372000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
1121000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
359000 | usd |
CY2024Q1 | ftek |
Contract With Customer Contracts In Progress Number Of Contracts Identified As Loss Contracts
ContractWithCustomerContractsInProgressNumberOfContractsIdentifiedAsLossContracts
|
0 | pure |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
6181000 | usd |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
6019000 | usd |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P12M | |
CY2024Q1 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
3769000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
4300000 | usd |
CY2024Q1 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
1507000 | usd |
CY2023Q4 | us-gaap |
Unbilled Receivables Current
UnbilledReceivablesCurrent
|
2285000 | usd |
CY2024Q1 | ftek |
Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
|
1677000 | usd |
CY2023Q4 | ftek |
Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
|
0 | usd |
CY2024Q1 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
262000 | usd |
CY2023Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
255000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
111000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7104000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6729000 | usd |
CY2024Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
976006 | |
CY2024Q1 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2251000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30385000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30296000 | |
CY2024Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
371000 | |
CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30756000 | |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30296000 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
270500 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.09 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
-0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
270500 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.09 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y3M21D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
11000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
270500 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.09 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P1Y3M21D | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
11000 | usd |
CY2024Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2850000 | |
CY2022Q2 | ftek |
Percentage Of Face Amount Of Letters Of Credit As Collateral
PercentageOfFaceAmountOfLettersOfCreditAsCollateral
|
1.50 | pure |
CY2022Q2 | ftek |
Payment Basis Points On Face Value Of Letters Of Credit
PaymentBasisPointsOnFaceValueOfLettersOfCredit
|
0.0250 | pure |
CY2024Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
888000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
2928000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
2029000 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3345000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
376000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1692000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
4482000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
2805000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
3245000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
218000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-658000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4957000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7287000 | usd |
CY2024Q1 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
49446000 | usd |
CY2023Q4 | us-gaap |
Noncurrent Assets
NoncurrentAssets
|
50388000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
761000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1279000 | usd |
CY2024Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
159000 | usd |
CY2023Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
159000 | usd |
CY2024Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
100000 | usd |
CY2023Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
103000 | usd |
CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
101000 | usd |
CY2024Q1 | ftek |
Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
|
264000 | usd |
CY2023Q4 | ftek |
Other Accrued Liabilities Miscellaneous Current
OtherAccruedLiabilitiesMiscellaneousCurrent
|
292000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1284000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1934000 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual Period Increase Decrease
StandardProductWarrantyAccrualPeriodIncreaseDecrease
|
0 | usd |
CY2024Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
159000 | usd |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.038 | pure |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | pure |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure |
CY2024Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | usd |